Actuate Therapeutics Inc
ACTU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$0 | -$0 | -$0 |
| % Margin | – | – | – |
| Net Income | -$0 | -$0 | -$0 |
| % Margin | – | – | – |
| EPS Diluted | -3.26 | -1.65 | -1.34 |
| % Growth | -97.6% | -23.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 |